A photo of Rajaram Nagarajan.

Rajaram Nagarajan, MD, MS


  • Co-Clinical Director, Cancer Survivorship Center
  • Professor, UC Department of Pediatrics

About

Biography

Dr. Nagarajan is a pediatric oncologist who specializes in the care of patients with cancer and patients who have completed their therapy.

BA: Pre-Medical Sciences, Lehigh University, Bethlehem, PA, 1991.

MD: Medical College of Pennsylvania, Philadelphia, PA, 1995.

Internship and Residency: Pediatrics, Medical College of Virginia, Richmond, VA, 1998.

Fellowship Training: Hematology / Oncology / BMT, University of Minnesota, Minneapolis, MN, 2002.

MS: Clinical Research, University of Minnesota, Minneapolis, MN, 2002.

Certifications: Pediatrics, Pediatric Hematology / Oncology.

Interests

Clinical bone tumors; late effects of pediatric cancer therapy

Services and Specialties

Cancer and Blood Diseases, Kidney Tumor, Sarcoma, Retinoblastoma

Interests

Research outcomes following cancer therapy and bone sarcomas

Research Areas

Oncology, Cancer and Blood Diseases

Insurance Information

Cincinnati Children's strives to accept a wide variety of health plans. Please contact your health insurance carrier to verify coverage for your specific benefit plan.

View Insurance Information

Publications

Selected

Cardiovascular Toxicities in Pediatric Cancer Survivors. Ryan, TD; Nagarajan, R; Godown, J. Cardiology Clinics. 2019; 37:533-544.

ASO Author Reflections: Minimizing Time in Hospital via Bone Biopsy or Other Means. Cooke-Barber, J; Brungardt, JG; Sorger, M; Pressey, JG; Turpin, B; Nagarajan, R; Szabo, S; Sorger, J; Johnson, N; Dasgupta, R. Annals of Surgical Oncology. 2023; 30:3666.

ASO Visual Abstract: Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care?. Cooke-Barber, J; Brungardt, JG; Sorger, M; Pressey, JG; Turpin, B; Nagarajan, R; Szabo, S; Sorger, J; Johnson, N; Dasgupta, R. Annals of Surgical Oncology. 2023; 30:3667.

Pediatric and Young Adult Image-Guided Percutaneous Bone Biopsy-A New Standard of Care?. Cooke-Barber, J; Brungardt, JG; Sorger, M; Pressey, JG; Turpin, B; Nagarajan, R; Szabo, S; Sorger, J; Johnson, N; Dasgupta, R. Annals of Surgical Oncology. 2023; 30:3658-3665.

Cardiac dysfunction in medulloblastoma survivors treated with photon irradiation. Cacciotti, C; Chordas, C; Valentino, K; Allen, R; Lenzen, A; Burns, K; Nagarajan, R; Manley, P; Pillay-Smiley, N. 2022; 9:338-343.

Linking EORTC QLQ-C-30 and PedsQL/PEDQOL physical functioning scores in patients with osteosarcoma. Budde, A; Baust, K; Weinhold, L; Bernstein, M; Bielack, S; Dhooge, C; Hjorth, L; Janeway, KA; Jenney, M; Krailo, MD; et al. European Journal of Cancer. 2022; 170:209-235.

Chemotherapy-induced thrombocytopenia in Ewing sarcoma: Implications and potential for romiplostim supportive care. Merjaneh, N; Young, J; Mangoli, A; Olsen, M; Setty, B; Lane, A; Nagarajan, R; Pressey, JG; Turpin, B. Pediatric Blood and Cancer. 2022; 69:e29548.

Relationship Between Caregiver Uncertainty, Problem-Solving, and Psychological Adjustment in Pediatric Cancer. Basile, NL; Chardon, ML; Peugh, J; Edwards, CS; Szulczewski, L; Morrison, CF; Nagarajan, R; El-Sheikh, A; Chaney, JM; Pai, AL H; et al. Journal of Pediatric Psychology. 2021; 46:1258-1266.

Long-term follow-up of surgical outcomes for patients with Wilms tumor and neuroblastoma. Cooke-Barber, J; Scorletti, F; Rymeski, B; Eshelman-Kent, D; Nagarajan, R; Burns, K; Jenkins, T; Dasgupta, R. Cancer. 2021; 127:3232-3238.

The impact of proton therapy on cardiotoxicity following radiation treatment. Frankart, AJ; Nagarajan, R; Pater, L. Journal of Thrombosis and Thrombolysis. 2021; 51:877-883.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey

4.6
Overall Patient Rating